Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Payables (2021 - 2024)

Opus Genetics (IRD) has disclosed Payables for 8 consecutive years, with $1.9 million as the latest value for Q3 2023.

  • On a quarterly basis, Payables rose 28.75% to $1.9 million in Q3 2023 year-over-year; TTM through Sep 2023 was $1.9 million, a 28.75% increase, with the full-year FY2022 number at $1.1 million, down 49.62% from a year prior.
  • Payables was $1.9 million for Q3 2023 at Opus Genetics, down from $2.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $2.3 million in Q2 2023 to a low of $1.1 million in Q4 2022.
  • A 3-year average of $1.7 million and a median of $1.8 million in 2022 define the central range for Payables.
  • Peak YoY movement for Payables: crashed 49.62% in 2022, then rose 28.75% in 2023.
  • Opus Genetics' Payables stood at $2.1 million in 2021, then plummeted by 49.62% to $1.1 million in 2022, then skyrocketed by 76.8% to $1.9 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Payables are $1.9 million (Q3 2023), $2.3 million (Q2 2023), and $2.2 million (Q1 2023).